Insider transactions

EDGAR

BIO-key International, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
1 transactions, 1,986 shares
Sum of shares × price per share: 3,793.26
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–7 of 7

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-17 Filed 2026-11-19DEPASQUALE MICHAEL W Director · Officer: Chief Executive Officer · Other: Chairman
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)1,9861.91
3,793.26

Derived: shares × price per share. Exact value 3793.26.

12,764Direct (D) No
F1
  • F1 Holdings do not include options to purchase 24 shares and 917 shares issuable upon exercise of warrants. All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026.
Open filing 0001437749-26-037627 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02Sullivan James David Officer: Chief Legal Officer · Other: SVP Strategy Compliance
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2503.83
957.5

Derived: shares × price per share. Exact value 957.50.

9,986Direct (D) No
F1, F2
  • F1 Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026.
Open filing 0001437749-26-022527 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02LACOUS MIRA K Officer: Chief Technology Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2503.83
957.5

Derived: shares × price per share. Exact value 957.50.

4,076Direct (D) No
F1, F2
  • F1 Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026.
Open filing 0001437749-26-022511 Read from the filing’s XML Dispute this row
2026-06-30 Filed 2026-07-02DEPASQUALE MICHAEL W Director · Officer: Chief Executive Officer · Other: Chairman
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2503.83
957.5

Derived: shares × price per share. Exact value 957.50.

10,778Direct (D) No
F1, F2
  • F1 Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 All share amounts reflect BIO-key's 1-for-10 reverse stock split, which was effective April 30, 2026.
Open filing 0001437749-26-022517 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-05Sullivan James David Officer: Chief Legal Officer · Other: SVP Strategy Compliance
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,5000.46
1,150

Derived: shares × price per share. Exact value 1150.00.

97,351Direct (D) No
F1, F2
  • F1 Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 Holdings do not include options to purchase 174 shares and 12,667 shares issuable upon exercise of warrants.
Open filing 0001437749-26-000379 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-05LACOUS MIRA K Officer: Chief Technology Officer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,5000.46
1,150

Derived: shares × price per share. Exact value 1150.00.

38,258Direct (D) No
F1, F2
  • F1 Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 Holdings do not include options to purchase 87 shares.
Open filing 0001437749-26-000384 Read from the filing’s XML Dispute this row
2025-12-31 Filed 2026-01-05DEPASQUALE MICHAEL W Director · Officer: Chief Executive Officer · Other: Chairman
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)2,5000.46
1,150

Derived: shares × price per share. Exact value 1150.00.

105,275Direct (D) No
F1, F2
  • F1 Represents shares acquired under the BIO-key International, Inc. 2021 Employee Stock Purchase Plan as amended in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • F2 Holdings do not include options to purchase 232 shares and 9,167 shares issuable upon exercise of warrants.
Open filing 0001437749-26-000373 Read from the filing’s XML Dispute this row

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
Alia Emmanuel DirectorCommon Stock 21,323D As of 2025-05-27 Open filing 4
DEPASQUALE MICHAEL W Director · Officer: Chief Executive Officer · Other: ChairmanCommon Stock 12,764D As of 2026-11-17 Open filing 4
Fiber Food Systems, Inc. 10% ownerCommon Stock 595,000D As of 2024-12-09 Open filing 3
Kwok Fong Wong Director · Officer: Managing Director, BIO-key HKCommon Stock 35,248D As of 2025-05-27 Open filing 4
LACOUS MIRA K Officer: Chief Technology OfficerCommon Stock 4,076D As of 2026-06-30 Open filing 4
Michel Robert J DirectorCommon Stock 23,569D As of 2025-05-27 Open filing 4
Sullivan James David Officer: Chief Legal Officer · Other: SVP Strategy ComplianceCommon Stock 9,986D As of 2026-06-30 Open filing 4
Welch Cecilia C Officer: Chief Financial OfficerCommon Stock 59,396D As of 2025-09-02 Open filing 4
Williams Cameron E. DirectorCommon Stock 21,950D As of 2025-05-27 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–7 of 7

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
StoneX Group Inc. Partly reported under another manager31,830 SH118,142 dollarsNot in the prior quarter’s filings read Open filing 0000913760-26-000042 Filed 2026-11-03 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager1,054 SH2,951 dollarsNot in the prior quarter’s filings read Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager759 SH2,125 dollarsNot in the prior quarter’s filings read Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
MORGAN STANLEY Partly reported under another manager200 SH560 dollarsNot in the prior quarter’s filings read Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
SBI Securities Co., Ltd. 30 SH84 dollarsNot in the prior quarter’s filings read Open filing 0001851815-26-000004 Filed 2026-10-22 Dispute this row
Global Retirement Partners, LLC 3 SH8 dollarsNot in the prior quarter’s filings read Open filing 0001580642-26-007620 Filed 2026-11-10 Dispute this row
Cassaday Co Wealth Management LLC 1 SH3 dollarsNot in the prior quarter’s filings read Open filing 0001963612-26-000006 Filed 2026-10-27 Dispute this row
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Institutional ownership reported on Form 13F

13F filers report holding between 0.00% and 1.66% of shares outstanding.

Quarter ending 2026-09-30, against 2,035,149 shares on the cover dated 2026-11-12.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 7433,8778,935
2026-06-30 0009,178
2026-03-31 1069,173
2025-12-31 0009,222
2025-09-30 0008,469
2025-06-30 0008,516
2025-03-31 0008,518
2024-12-31 0008,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Armistice Capital, LLC Common Stock, $0.0001 par value per share4.99359,703.0006/30/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 1Open filing 0001172661-25-003628 Dispute this row
Steven Boyd Common Stock, $0.0001 par value per share4.99359,703.0006/30/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 1Open filing 0001172661-25-003628 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,844,380 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015234,246
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to BIO-key International, Inc.